Switching Therapy in Chronic Myeloid Leukemia
0 Pogledi
• 07/08/23
0
0
Ugraditi
administrator
Pretplatnici
The panelists, Jorge Cortes, MD; Javier Pinilla-Ibarz, MD, PhD; David Snyder, MD, FACP; and Harry Erba, MD, PhD, share perspectives on clinical scenarios in chronic myeloid leukemia that may prompt a treatment change.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari